SPES Tech Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
SPES Tech General Information
Description
Developer of biomaterials via protein and genetic engineering techniques intended for higher cell viability. The company focuses on the hydrogel technology as an injectable carrier for cell therapy, enabling researchers to achieve better cell retention, higher cell viability, and greater proliferation to restore human health.
Contact Information
Website
www.spes-tech.comCorporate Office
- Lab Bench 5a-c, Unit 708-716, 7/F & Room 609, 6/F, Building 17W No. 17 Science Park West A
- Pak Shek Kok
- Hong Kong
- Hong Kong
Corporate Office
- Lab Bench 5a-c, Unit 708-716, 7/F & Room 609, 6/F, Building 17W No. 17 Science Park West A
- Pak Shek Kok
- Hong Kong
- Hong Kong
SPES Tech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | Completed | Out of Business | ||||
| 2. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 1. Grant | 15-Jul-2019 | $6.4K | Completed | Startup |
SPES Tech FAQs
-
When was SPES Tech founded?
SPES Tech was founded in 2019.
-
Where is SPES Tech headquartered?
SPES Tech is headquartered in Hong Kong, Hong Kong.
-
What industry is SPES Tech in?
SPES Tech’s primary industry is Biotechnology.
-
Is SPES Tech a private or public company?
SPES Tech is a Private company.
-
What is SPES Tech’s current revenue?
The current revenue for SPES Tech is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process